Thoracic Cancer ISSN 1759-7706
ORIGINAL ARTICLE
Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma Jiawei Zou1†, Tangfeng Lv2†, Suhua Zhu2, Zhenfeng Lu3, Qin Shen3, Leilei Xia2, Jie Wu2, Yong Song1,2 & Hongbing Liu2 1 Department of Respiratory Medicine, Jinling Hospital, Southern Medical University, Nanjing, China 2 Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China 3 Department of Pathology, Jinling Hospital, Nanjing, China
Keywords Computed tomography (CT); epidermal growth factor receptor (EGFR); lung adenocarcinoma. Correspondence Yong Song and Hongbing Liu, Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing, Jiangsu Province 210002, China. Tel: +86 25 8086 3591 Fax: +86 25 8086 3591 Email:
[email protected];
[email protected] †
These authors contributed equally to this work. Received: 12 January 2017; Accepted: 27 February 2017. doi: 10.1111/1759-7714.12436 Thoracic Cancer 8 (2017) 260–270
Abstract Background: The relationship between epidermal growth factor receptor (EGFR) gene mutation status, preoperative computed tomography (CT), and clinical features in patients with small peripheral lung adenocarcinoma (